Skip to main content

Table 2 Results of the somatostatin analogue test

From: Familial dysalbuminemic hyperthyroxinemia combined with Graves’ disease: a rare case report

The somatostatin analogue test

0 h

2 h

4 h

6 h

8 h

24 h

48 h

72 h

TSH (μIU/mL)

1.041

0.471

0.307

0.252

0.329

0.204

0.235

0.244

FT3(pg/mL)

3.53

3.76

3.70

3.57

3.51

3.34

3.14

2.86

FT4(ng/dL)

1.91

2.10

1.91

1.74

1.92

1.68

1.62

1.68

  1. Methods of the somatostatin analogue test: Somatostatin analogue was administered subcutaneously nine times at a dosage of 100 μg every 8 h. Serum TSH, FT3 and FT4 levels were measured at 0, 2, 4, 6, 8, 24, 48, and 72 h after the first injection
Back to article page

BMC Endocrine Disorders

ISSN: 1472-6823

Contact us